Stephanie Coury, MS, CGC
Stephanie Coury, MS, CGC, is Adjunct Associate Professor in the School of Health and Rehabilitation Sciences and teaches in the Master of Science in Genetic Counseling program at MGH Institute of Health Professions.
Ms. Coury has worked as a clinical genetic counselor for over 12 years, working in pediatric, metabolic, adult, and prenatal genetic clinics. She currently works as a senior genetic counselor at Boston Children’s Hospital. In addition to her clinical roles, she also supervises and teaches genetic counseling students, and is co-director of the Harvard Medical School Genetics Training Program (HMSGTP) Advanced Human Genetics Course.
She is a team member of the Boston Children’s Hospital/ Dana Farber Cancer Institute Pediatric Cancer Risk Program. Ms. Coury is an Executive Committee Member of the Autism Spectrum Center at Boston Children’s Hospital. She is also a member of the New England Regional Genetics Group, and the New England Genetics Collaborative.
Ms. Coury has given numerous genetic lectures and presentations at national and international genetics meetings, as well as to high school, undergraduate, and post-graduate students.
BS, Biology, Providence College, Providence, RI
MS, Genetic Counseling, University of Pittsburgh, Pittsburgh, PA
Okur V, Cho MT, van Wijk R, van Oirschot B, Picker J, Coury SA, Grange D, Manwaring L, Krantz I, Muraresku CC, Hulick PJ, May H, Pierce E, Place E, Bujakowska K, Telegrafi A, Douglas G, Monaghan KG, Begtrup A, Wilson A, Retterer K, Anyane-Yeboa K, Chung WK. De novo variants in HK1 associated with neurodevelopmental abnormalities and visual impairment. Eur J Hum Genet. 2019 Feb 18.
Zhong C, Song H, Weiss A, Tan WH, Coury S, Huang J. Myofibromatosis presenting as reticulated vascular changes and subcutaneous atrophy in patient with somatic mosaicism of PDGFRB mutation. Br J Dermatol. Br J Dermatol. 2018 Jul 12.
Coury SA, Schneider KA, Schienda J, Tan WH. Recognizing and Managing Children with a Pediatric Cancer Predisposition Syndrome: A Guide for the Pediatrician. Pediatr Ann. 2018 May 1;47(5):e204-e216.
Newton SA, Agrawal P, Desai N, deFerranti SD, Joshi M, Eagan J, Rohr F, Connolly M, Bennett MJ, Berry GT. An ultra-rare defect due to glycerol-3-phosphate dehydrogenase deficiency redirects hepatic lipid metabolism causing hypertriglyceridemia and massive hepatic steatosis. Platform presentation at the International Congress of Inborn Errors of Metabolism (ICIEM), Barcelona, Spain, 2013.
Newton SA, Poduri A, Bergin AM, Prabhu SP, Chopra S, Sahin M, Picker J, Kothare S, Berry GT. Myo-inositol treatment reduces seizures and improves clinical outcome in a new patient with the ultrarare phospholipase C beta 1 deficiency. Platform presentation at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium, Geneva, Switzerland, 2011.